Capricor Therapeutics, Inc.

Cell & Gene Therapy
Listed: NASDAQ: CAPRHas an LEI
11Open roles9 posted in 30 days+1 this week
$135kMedian advertised pay$90k – $310k
Lately:+1 roles posted this week14 news stories in 90 daysFollow changes →

Facts

as of Nov 17, 2026

Developing Transformative Cell and Exosome-based Therapeutics. Capricor Therapeutics is a biotechnology company offering a new approach on drug development in Duchenne muscular dystrophy and beyond. We are patient-focused first, while advancing precision medicine.

It is hiring: 11 open roles, 9 of them posted in the last 30 days.

Legal name
CAPRICOR THERAPEUTICS, INC.
Headquarters
Beverly Hills, United States
Founded
2023
Employees
201-500estimated range
Listing
NASDAQ: CAPR
Open roles
11Alion job postings
Register numbers
NAME capricor therapeutics inc
Website
capricor.com

As of Nov 17, 2026, Alion lists 11 open roles at Capricor Therapeutics, Inc. Capricor Therapeutics, Inc. is headquartered in Beverly Hills, United States. It was founded in 2023. The median pay stated in its open roles is $135k, across 11 postings that state pay.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
CAPRICOR THERAPEUTICS, INC.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Hiring at full speed: most open roles are fresh.

Legal is the largest family, 18 of open roles.

9Posted in 30 days82% of open roles are fresh
36%Remote roles4 of 11
1Hiring offices
Can they hire you from United States?by your location
Likely
8 open roles are in your country: you apply locally, no move needed.
United States8On site
Remote, from elsewhere4Rare
No posting offers visa sponsorship. Remote roles: 4.
Alion signals0-100
Demand37
Pay35
Your chance52
How badly they need people, whether they pay, how realistic getting in is.
Where the openings areshare of open roles · trend
Legal18▲
Sales18▲
Industrial Engineering18▲
Networking9▲
Analytics9▲
Finance9▲
Newest roles
Senior Director, Field Reimbursement
$246k – $318k per year · Remote (United States) · Full-Time · 10+ years exp · Bachelor's Degree
Senior Director, Head of Payer Strategy & Engagement
$246k – $318k per year · Remote (United States) · Full-Time · 12+ years exp · Bachelor's Degree
Quality Assurance Associate II - Night Shift
$75k – $90k per year · In office · Full-Time · Bachelor's Degree · San Diego
Quality Control Associate - Environmental Monitoring
$65k – $85k per year · In office · Full-Time · 2+ years exp · Bachelor's Degree · San Diego
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family

What its postings pay, by level.

$135kMedian
$90k – $310kTypical rangeUSD a year
$318kHighest paying roleSenior Director, Head of Patient Services
Pay by levelmiddle half of stated pay, median marked
Middle3$110k$90k – $110k
Head+5$315k$310k – $318k
$0$88k$175k$263k$350k
Source: the pay stated in the company's postings, normalised to USD a year

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
San DiegoBusiest site
Loading the map
SiteTypeOpen rolesHires most forEngineering
Beverly Hills United StatesHeadquarters0
San Diego United StatesRegional office8Industrial Engineering, Networking, Administrative25%
Source: office addresses in postings and company registers

Ranked #7 by open roles among its 11 closest peers.

#CompanyHQOpen rolesSize
1AlnylamCambridge, United States931001-5000
2Legend BiotechSomerset, United States511001-5000
3Kite PharmaSanta Monica, United States441001-5000
4Iovance BiotherapeuticsSan Carlos, United States24201-500
54D Molecular TherapeuticsEmeryville, United States2051-200
6ElevateBioWaltham, United States13201-500
7Capricor Therapeutics, Inc.Beverly Hills, United States11201-500
8GenetixbiotxSomerville, United States1151-200
Source: Alion's similar-companies engine (industry segments, technologies, headquarters country, size)

Financials

1 public grant on record, $1.7M in total.

$1.7MPublic grants1 public grant
Money by yearUSD, rounds and grants
2016$1.7M1 record
Largest rounds and grants
2016
$1.7M
Sources: funding announcements, grant and company registers

Technologies named in job postings at Capricor Therapeutics, Inc. over the last 12 months, by layer, with the share of postings for each.

24Technologies in use
6Postings analysed
66/100Stack modernity
LanguagesPowerShell
DatabasesSnowflake
Sign in to see how your skills match this stackSign In
Full Capricor Therapeutics, Inc. tech stack24 technologies · by team · pay by technology · changes · similar stacks
Source: the technologies named in the company's postings and on its site

Milestones

Nov 2026
Went public NASDAQ: CAPR
2023
Founded
Sep 15, 2016
Won a grant $1.7M · CORDIS
Each milestone is dated by its source: registers, filings, the press

Newsroom

top 2%Web presenceof 133.2M domains by links, Common Crawl
Sep 302026
News · Blockonomi
Capricor (CAPR) stock rose after releasing 24-month deramiocel data from its Duchenne trial ahead of the FDA's November 22 decision deadline.
Sep 302026
News · CoinCentral
Capricor Therapeutics (CAPR) stock rose after new Phase 3 data on Duchenne drug deramiocel ahead of a November 22 FDA decision.
Sep 292026
Press release · The Globe and Mail
Detailed price information for Capricor Therap (CAPR-Q) from The Globe and Mail including charting and trades.
Sep 252026
News · NewMediaWire
NEW YORK, NY - September 25, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (
Sep 242026
News · NewMediaWire
NEW YORK, NY - September 24, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (
Sep 242026
Press release · PRNewswire
/PRNewswire/ -- SueWallSt alerts investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) that a securities class action has been filed on behalf of...
Sources: the outlets named on each headline, each story once